Articles

  • 3 weeks ago | thegoldentimes.com.au | Jamie Nemtsas |Nicholas Way |Duncan Hughes

    For Fisher & Paykel Healthcare (ASX:FPH), it was all going so swimmingly. A strong first half saw the New Zealand-based medical-device maker post a stellar 18 per cent jump in operating revenue to $NZ951 million ($865 million) for the six months to September 30, 2024, while net profit after tax (NPAT) rocketed 43 per cent to $NZ153 million ($139 million) compared with the corresponding period last year.

  • 3 weeks ago | thegoldentimes.com.au | Duncan Hughes |Nicholas Way |Jamie Nemtsas

    A brother and sister’s fight over the water rights to their deceased parents’ rural property highlights the importance of a well-drafted will to avoid costly confusion. Rodney Troy was bequeathed rural property valued at about $120,000 and his sister, Deborah, property worth around $1.9 million, when their mother, Florida, died, aged 91, in 2019. Their father and Florida’s husband, Thomas, died in 2015.

  • 4 weeks ago | thegoldentimes.com.au | Jamie Nemtsas |Nicholas Way |Duncan Hughes

    The Challenger Group (ASX: CGF) interim numbers looked solid – as was the confident prediction for the full-year result to June 30, 2025. In the first half, the net profit after tax (NPAT) was up 12 per cent to $225 million, normalised return on equity (post-tax) was up 11.6 per cent and group assets under management were $131 billion, up 12 per cent. For shareholders, the interim dividend was up 12 per cent to 14.5 cents a share (fully franked).

  • 1 month ago | thegoldentimes.com.au | Kevin Pelham |Duncan Hughes |Jamie Nemtsas

    For the estimated 440,000 retirees who opt to manage their own investment savings via a self-managed super fund (SMSF), a recent research report showing their funds, on average, outperformed the APRA-regulated funds over the five years to June 30, 2023, must have been as welcomed as the flowers in May.

  • 1 month ago | thegoldentimes.com.au | Jamie Nemtsas |Duncan Hughes |David Murphy

    The first-half numbers for Coles (ASX:COL) to December 31, 2024, were solid, with sales ahead 3.7 per cent to $23 billion, outstripping its major rival Woolworths – the latter was plagued by industrial trouble before Christmas – which could only increase revenue 2.7 per cent.

Contact details

Socials & Sites

Try JournoFinder For Free

Search and contact over 1M+ journalist profiles, browse 100M+ articles, and unlock powerful PR tools.

Start Your 7-Day Free Trial →